Business · 02/11/2001Updated: 10/17/2026 · 1 min read
FDA Clarifies Indications for Doxycycline and Penicillin G Procaine in Inhalational Anthrax Treatment
The Food and Drug Administration (FDA) has updated its approved indications for doxycycline and penicillin G procaine to include treatment for inhalational exposure to Bacillus anthracis, the bacterium that causes anthrax, and is providing recommended dosing regimens for these products in this context.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →